Notably, MFNG levels were significantly lower in the tumors included in the CRC subtype 247 (Supplementary Fig. 4D), which is the most frequent and is characterized by a marked activation of the WNT and MYC pathways. This evidence concerns the gene MFNG and colorectal carcinoma.